Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP
Status:
Not yet recruiting
Trial end date:
2026-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this open-label phase IIa clinical trial study is to evaluate the safety and
preliminary efficacy of hBMMSC intravenous treatment in patients with aPAP.